Tehran University of Medical Sciences

Science Communicator Platform

Share By
Il-35, a Double-Edged Sword in Cancer Publisher Pubmed



Yazdani Z1 ; Rafiei A1 ; Golpour M2 ; Zafari P1, 2 ; Moonesi M3 ; Ghaffari S4, 5
Authors

Source: Journal of Cellular Biochemistry Published:2020


Abstract

Interleukin 35 (IL-35), a cytokine mainly produced by regulatory T cells (Treg cells), is composed of an Epstein-Barr virus–induced gene 3 β-chain and an IL-12 p35 α-chain. IL-35 causes tumorigenicity in cancer, protects cancer cells against apoptosis, and facilitates cancer progression. However, a few reports have referred to its contradictory roles in cancer prevention. Therefore, the exact purpose of this cytokine in cancer development has become a fundamental question that needs to be answered. In this review, we explain the structure of IL-35 and its receptors and their different signaling pathways. Finally, the function of IL-35 in some cancers and the possible application of this cytokine in approaches for cancer therapy have been discussed. © 2019 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. Il-25 Impact on Malignant B Cells Survival and T Cells Activation in Chronic Lymphocytic Leukemia, Iranian Journal of Allergy# Asthma and Immunology (2023)
2. The Role of the Il-33/St2 Immune Pathway in Autoimmunity: New Insights and Perspectives, Immunological Investigations (2022)
3. Il-33/St2 Axis in Autoimmune Disease, Cytokine (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Ahmad Reza Jamshidi (2)
Other Related Docs
4. Il-17 and Colorectal Cancer: From Carcinogenesis to Treatment, Cytokine (2019)
5. Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?, Clinical Laboratory (2018)
6. The Possible Role of Interleukin-35 and Its Therapeutic Potential in Pemphigus, International Immunopharmacology (2017)
7. Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly, International Immunopharmacology (2020)
8. Human Il-23 Is Essential for Ifn-Γ–Dependent Immunity to Mycobacteria, Science Immunology (2023)
9. The Role of T Helper 17 and Regulatory T Cells in Tumor Microenvironment, Immunopharmacology and Immunotoxicology (2019)
10. Molecular Mechanisms of the Action of Vitamin a in Th17/Treg Axis in Multiple Sclerosis, Journal of Molecular Neuroscience (2015)
11. Role of Innate Immune System in the Pathogenesis of Ankylosing Spondylitis, Biomedicine and Pharmacotherapy (2018)
12. Camp-Pde Signaling in Copd: Review of Cellular, Molecular and Clinical Features, Biochemistry and Biophysics Reports (2023)
13. The Roles of Cd4+ T-Cells in Tumor Immunity, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
14. Innate Immune-Related Cells and Cytokines in Spondyloarthropathies, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular# Molecular and Environmental Factors (2021)
15. Interleukin-23 Receptor Gene Polymorphisms in Iranian Patients With Juvenile Systemic Lupus Erythematosus, Allergologia et Immunopathologia (2020)
16. The Role of Th1 and Th17 Cells in Glomerulonephritis, Journal of Nephropathology (2015)
17. Altered Microrna Expression and Immunosuppressive Cytokine Production by Regulatory T Cells of Ulcerative Colitis Patients, Immunological Investigations (2016)
18. Autoimmune Diseases, Clinical Immunology (2022)
19. Effects of Vitamin D Supplementation on Serum Levels and Gene Expression of Il-10 and Il-35 Among Women With Unexplained Recurrent Spontaneous Abortion, Recent Advances in Inflammation and Allergy Drug Discovery (2026)
20. Regulatory T Cells in Breast Cancer As a Potent Anti-Cancer Therapeutic Target, International Immunopharmacology (2020)